Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EnBio HoldingsTSE:6092 -1.78%58 5-Year Yield-on-Cost % is 1.16 as of Aug. 18, 2026, which is 11% below its 10-year median of 1.30. GuruFocus rates TSE:6092 with a GF Score™ of 58/100 and a GF Value™ of 円805.18 (Fairly Valued). The stock has 7 warning signs investors should review. Among 597 Business Services companies, EnBio Holdings ranks worse than 83.92% on this metric.
EnBio Holdings's yield on cost for the quarter that ended in Mar. 2026 was 1.16.
The historical rank and industry rank for EnBio Holdings's 5-Year Yield-on-Cost % or its related term are showing as below:
TSE:6092'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.99 Med: 1.3 Max: 1.5
Current: 1.16
During the past 13 years, EnBio Holdings's highest Yield on Cost was 1.50. The lowest was 0.99. And the median was 1.30.
TSE:6092's 5-Year Yield-on-Cost % is ranked worse than 83.92% of 597
companies
in the Business Services industry
Industry Median: 4
vs TSE:6092: 1.16
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
EnBio Holdings 5-Year Yield-on-Cost % Related Terms
TSE:6092 vs CTAS, CPRT, GPN: 5-Year Yield-on-Cost % Comparison
For the Specialty Business Services subindustry, EnBio Holdings's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
EnBio Holdings 5-Year Yield-on-Cost % vs Business Services Industry
For the Business Services industry and Industrials sector, EnBio Holdings's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where EnBio Holdings's 5-Year Yield-on-Cost % falls into.
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Therefore, Yield-on-Cost of EnBio Holdings is calculated as
EnBio Holdings (TSE:6092) has a 5-Year Yield-on-Cost % of 1.16 as of Aug. 18, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on EnBio Holdings and its competitors. This is 11% below median its historical median of 1.30. Over the past decade, EnBio Holdings' 5-Year Yield-on-Cost % has ranged from 0.99 to 1.50. According to the industry distribution chart, EnBio Holdings ranks #501 out of 597 companies in the Business Services industry, placing it in the top 83.9%.
Is EnBio Holdings' 5-Year Yield-on-Cost % too high?
EnBio Holdings' current 5-Year Yield-on-Cost % of 1.16 is 11% below median its 10-year median of 1.30. Over the past 10 years, this metric has ranged from a low of 0.99 to a high of 1.50. The Business Services industry median 5-Year Yield-on-Cost % is 4.00. EnBio Holdings' value of 1.16 is 71% below this industry median. Based on the distribution chart, EnBio Holdings ranks #501 out of 597 companies in the Business Services industry, which is in the bottom quartile relative to peers. Overall, EnBio Holdings has a GF Score™ of 58/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does EnBio Holdings' 5-Year Yield-on-Cost % compare to CTAS and CPRT?
According to the Business Services industry distribution chart, EnBio Holdings ranks #501 out of 597 companies for 5-Year Yield-on-Cost %. This places EnBio Holdings in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 4.00. EnBio Holdings' value of 1.16 is 71% below this benchmark. Historically, EnBio Holdings' own 5-Year Yield-on-Cost % has ranged from 0.99 to 1.50 over the past decade. While the company's 10-year median is 1.30 vs. the industry median of 4.00, EnBio Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Business Services company?
The median 5-Year Yield-on-Cost % among Business Services companies is 4.00, based on 597 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. EnBio Holdings's current 5-Year Yield-on-Cost % of 1.16 is 71% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on EnBio Holdings and its competitors. For the Business Services industry, the median 5-Year Yield-on-Cost % is 4.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. EnBio Holdings's current 5-Year Yield-on-Cost % is 1.16, which is 11% below median its own 10-year median of 1.30. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EnBio Holdings stock overvalued right now?
Based on GuruFocus' analysis, EnBio Holdings (TSE:6092) is currently considered Fairly Valued. The stock's GF Value™ is 円805.18, compared to a current price of 円884.00 — trading 9.8% above its estimated fair value. The current 5-Year Yield-on-Cost % is 1.16, which is 11% below median its 10-year median of 1.30 and 71% below the Business Services industry median of 4.00. EnBio Holdings' overall GF Score™ is 58/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For EnBio Holdings (TSE:6092), the current 5-Year Yield-on-Cost % is 1.16 as of Aug. 18, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is EnBio Holdings (TSE:6092) Overvalued in 2026?
Based on GuruFocus' analysis, EnBio Holdings stock appears to be overvalued.
The current stock price of 円884.00 is trading 9.8% above its estimated GF Value™ of 円805.18.
GuruFocus considers EnBio Holdings to be Fairly Valued.
Key valuation signals for TSE:6092:
5-Year Yield-on-Cost %: 1.16 (11% below median its 10-year median of 1.30)
GF Value™: 円805.18 vs. price of 円884.00 (9.8% above fair value)
Industry Position: 71% below the Business Services median (#501 of 597)
No single metric tells the full story. See the TSE:6092 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
EnBio Holdings Inc is a Japanese company engaged in environmental solution business, tools and chemicals business, and brownfield revitalization business. The environmental business involves investigation, remediation and risk management consulting of contaminated soil and groundwater; Tools and chemicals business involves sales of chemicals used for environmental work such as site investigation and remediation; and brownfield revitalization business which involves purchasing and regeneration of brownfields. The objective of the company is solving soil and groundwater contamination issues.
58GF Score
Get the complete analysis for TSE:6092
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:6092 has been successfully added to your 
